All Stories

  1. Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome

    Article • Clinical Journal of the American Society of Nephrology, December 2022, American Society of Nephrology

    Kjell Tullus

  2. Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study

    Article • Journal of the American Society of Nephrology, March 2022, American Society of Nephrology

    Kjell Tullus, Dr Chang-Yien Chan